Nucleophosmin and nucleolin regulate K-Ras signaling

Communicative and Integrative Biology

Volumn 3, Issue 2, 2010, Pages 188-190

  Inder, Kerry L ^a   Hill, Michelle M ^b   Hancock, John F ^c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

ERK activation; K Ras; NPM; Nucleolin; Plasma membrane nanoclusters

Indexed keywords

EID: 84872083841     PISSN: None     EISSN: 19420889     Source Type: Journal    
DOI: 10.4161/cib.3.2.10923     Document Type: Article

References (21)

1. Harding A, Tian T, Westbury E, Frische E, Hancock JF. Subcellular localization determines MAP kinase signal output. Curr Biol 2005; 15:869-73.
2. Inder K, Harding A, Plowman SJ, Philips MR, Parton RG, Hancock JF. Activation of the MAPK module from different spatial locations generates distinct system outputs. Mol Biol Cell 2008; 19:4776-84.
3. Tian T, Harding A, Inder K, Plowman S, Parton RG, Hancock JF. Plasma membrane nanoswitches generate high-fidelity Ras signal transduction. Nat Cell Biol 2007; 9:905-14.
4. Abankwa D, Hanzal-Bayer M, Ariotti N, Plowman SJ, Gorfe AA, Parton RG, et al. A novel switch region regulates H-ras membrane orientation and signal output. EMBO J 2008; 27:727-35.
5. Hancock JF, Parton RG. Ras plasma membrane signalling platforms. Biochem J 2005; 389:1-11.
6. Bos JL. ras oncogenes in human cancer: a review. Cancer Res 1989; 49:4682-9.
7. Downward J. Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer 2003; 3:11-22.
8. Inder KL, Lau C, Loo D, Chaudhary N, Goodall A, Martin S, et al. Nucleophosmin and nucleolin regulate K-Ras plasma membrane interactions and MAPK signal transduction. J Biol Chem 2009; 284:28410-9.
9. Borer RA, Lehner CF, Eppenberger HM, Nigg EA. Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell 1989; 56:379-90.
10. Ginisty H, Amalric F, Bouvet P. Nucleolin functions in the first step of ribosomal RNA processing. EMBO J 1998; 17:1476-86.
11. Szebeni A, Olson MO. Nucleolar protein B23 has molecular chaperone activities. Protein Sci 1999; 8:905-12.
12. Plowman SJ, Muncke C, Parton RG, Hancock JF. H-ras, K-ras and inner plasma membrane raft proteins operate in nanoclusters with differential dependence on the actin cytoskeleton. Proc Natl Acad Sci USA 2005; 102:15500-5.
13. Prior IA, Harding A, Yan J, Sluimer J, Parton RG, Hancock JF. GTP-dependent segregation of H-ras from lipid rafts is required for biological activity. Nat Cell Biol 2001; 3:368-75.
14. Prior IA, Muncke C, Parton RG, Hancock JF. Direct visualization of Ras proteins in spatially distinct cell surface microdomains. J Cell Biol 2003; 160:165-70.
15. Plowman SJ, Ariotti N, Goodall A, Parton RG, Hancock JF. Electrostatic interactions positively regulate K-Ras nanocluster formation and function. Mol Cell Biol 2008; 28:4377-85.
16. Di Segni A, Farin K, Pinkas-Kramarski R. Identification of nucleolin as new ErbB receptors-interacting protein. PLoS ONE 2008; 3:2310.
17. Farin K, Di Segni A, Mor A, Pinkas-Kramarski R. Structure-function analysis of nucleolin and ErbB receptors interactions. PLoS One 2009; 4:6128.
18. Shalom-Feuerstein R, Plowman SJ, Rotblat B, Ariotti N, Tian T, Hancock JF, Kloog Y. K-ras nanoclustering is subverted by overexpression of the scaffold protein galectin-3. Cancer Res 2008; 68:6608-16.
19. Lim MJ, Wang XW. Nucleophosmin and human cancer. Cancer Detect Prev 2006; 30:481-90.
20. Falini B, Bolli N, Shan J, Martelli MP, Liso A, Pucciarini A, et al. Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. Blood 2006; 107:4514-23.
21. Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, Pasqualucci L, et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyo-type. N Engl J Med 2005; 352:254-66.